The Latest Cardiac and Vascular News
PARIS–(BUSINESS WIRE)–Edwards Lifesciences (NYSE: EW) today announced new economic and clinical evidence on severe aortic stenosis (AS) presented as a late-breaking clinical trial at EuroPCR 2025, further contributing to the extensive body of research on this disease. The results of a new real-world study of more than 24,000 patients demonstrated […]
MINNEAPOLIS, May 22, 2025 /PRNewswire/ — Phraxis Inc., a Minneapolis-based medical device company, marks a major milestone with FDA approval of the EndoForce™ Connector for Endovascular Venous Anastomosis (EndoForce™) — a pivotal development in the evolution of dialysis access technology….
Number one doctor and pharmacist-recommended blood pressure monitor brand introduces blood pressure monitors with OMRON Intellisense™ AFib HOFFMAN ESTATES, Ill., May 21, 2025 /PRNewswire/ — Heralding an evolution of the blood pressure monitoring experience, heart health leader OMRON…
RapidAI detects 33% more MeVOs than Viz.ai, with new real-world data presented at ESOC highlighting superior accuracy and deeper clinical insights San Mateo, Calif. — May 21, 2025 // RapidAI, the gold standard and global leader in neurovascular AI-based clinical decision support and enterprise radiology solutions, today announced new study […]
TACOMA, Wash., May 21, 2025 /PRNewswire/ — Revalesio, a clinical-stage pharmaceutical company developing treatments for acute and chronic neurological disorders, today announced data from a post hoc analysis of its completed Phase 2 RESCUE clinical trial, showing that ischemic stroke…
SOUTH OGDEN, UT – May 21, 2025 –- MultiFunctional Imaging LLC (MFI) today announced the upcoming oral presentation on using the mfiVerseä software for immediate back-to-back rest-stress cardiac PET scanning with F18 flurpiridaz for the evaluation of patients with known or suspected heart disease. The Society of Nuclear Medicine and […]
SUNNYVALE, Calif., May 21, 2025 (GLOBE NEWSWIRE) — BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced that BioCardia’s CEO, Peter Altman, Ph.D., will participate in a fireside chat at the Alliance Global Partners Virtual Healthcare Company Showcase hosted by Jim Molloy, Managing Director, Equity Research Biotechnology & Specialty Pharmaceuticals at A.G.P., on May 21, 2025.
New ultrasound catheter delivers superior image quality,i,ii peak maneuverability and seamless CARTO™ 3 System integrationi, giving physicians improved visualizationii for added confidence during cardiac ablation procedures IRVINE, Calif., May 21, 2025 /PRNewswire/ — Johnson & Johnson…
Strategic acquisition brings generative AI into structured workflows, reinforcing Kailo’s mission to deliver long-term impact through trusted, collaborative innovation. MELBOURNE, May 21, 2025 /PRNewswire/ – Kailo Medical, a global leader in structured reporting for medical imaging, today…
Route 92 Medical announces results of the SUMMIT MAX randomized clinical trial and receipt of a 510(k) clearance for the HiPoint 88 Reperfusion System.
